https://doi.org/10.1371/journal.pone.0153550
S
Sharareh Gholamin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
110
Papers
3.5K
Citations
22
h-index
30
i10-index
Sharareh Gholamin is an academic researcher from City Of Hope National Medical Center. The author has contributed to research in topics: Protein Degradation and Inhibitors & Glioma Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 22, co-authored 94 publications.
ORCID: 0000-0001-7425-6074Papers by this author
worksAnti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
2016 · PLoS ONE · 320 citations
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
2014 · Nature Medicine · 312 citations
https://doi.org/10.1038/nm.3613
The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the <scp>PKC</scp> δ‐dependent inhibition of the <scp>AKT</scp> pathway
2016 · EMBO Molecular Medicine · 51 citations
https://doi.org/10.15252/emmm.201505421
Brucella endocarditis, a report of 14 cases (1991–2009)
2010 · Journal of Infection · 18 citations
https://doi.org/10.1016/j.jinf.2010.03.027
Biomarker Analysis in CLEOPATRA: Searching for a Sensitive Prognostic Factor in Breast Cancer
2015 · Journal of Clinical Oncology · 10 citations
https://doi.org/10.1200/jco.2014.60.4702
Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
2018 · Nature Communications · 2 citations
https://doi.org/10.1038/s41467-018-07182-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat